These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17016604)

  • 1. p38MAPK inhibitor SB203580 sensitizes human SNU-C4 colon cancer cells to exisulind-induced apoptosis.
    Lim SJ; Lee YJ; Lee E
    Oncol Rep; 2006 Nov; 16(5):1131-5. PubMed ID: 17016604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-tocopheryl succinate sensitizes human colon cancer cells to exisulind-induced apoptosis.
    Lim SJ; Lee YJ; Park DH; Lee E; Choi MK; Park W; Chun KH; Choi HG; Cho JS
    Apoptosis; 2007 Feb; 12(2):423-31. PubMed ID: 17191116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells.
    Sun Y; Sinicrope FA
    Mol Cancer Ther; 2005 Jan; 4(1):51-9. PubMed ID: 15657353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites.
    Rice PL; Goldberg RJ; Ray EC; Driggers LJ; Ahnen DJ
    Cancer Res; 2001 Feb; 61(4):1541-7. PubMed ID: 11245463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ERK and activation of p38 are involved in diallyl disulfide induced apoptosis of leukemia HL-60 cells.
    Tan H; Ling H; He J; Yi L; Zhou J; Lin M; Su Q
    Arch Pharm Res; 2008 Jun; 31(6):786-93. PubMed ID: 18563362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases.
    Park JH; Kim EJ; Jang HY; Shim H; Lee KK; Jo HJ; Kim HJ; Yang SH; Jeong ET; Kim HR
    Oncol Rep; 2008 Aug; 20(2):379-84. PubMed ID: 18636201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the ERK1/2 and p38 kinase pathways with nitric oxide-induced apoptosis and cell cycle arrest in colon cancer cells.
    Jeon HK; Choi SU; Jung NP
    Cell Biol Toxicol; 2005 Mar; 21(2):115-25. PubMed ID: 16142585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
    Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
    J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
    Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
    Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
    Zhou X; Wang C; Tian J; Wang Y; Li Y; Hu Z; Li R
    Mol Med Rep; 2015 Aug; 12(2):2643-9. PubMed ID: 25936991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEK and p38MAPK inhibitors potentiate TNF-alpha induced apoptosis in U937 cells.
    Nakada S; Kawano T; Saito-akita S; Iwase S; Horiguchi-Yamada J; Ohno T; Yamada H
    Anticancer Res; 2001; 21(1A):167-71. PubMed ID: 11299730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
    Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
    Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways.
    Rice PL; Peters SL; Beard KS; Ahnen DJ
    Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione.
    Fan Y; Chen H; Qiao B; Luo L; Ma H; Li H; Jiang J; Niu D; Yin Z
    Mol Cells; 2007 Feb; 23(1):30-8. PubMed ID: 17464209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.
    Chatzinikolaou G; Nikitovic D; Berdiaki A; Zafiropoulos A; Katonis P; Karamanos NK; Tzanakakis GN
    Cell Prolif; 2010 Feb; 43(1):9-18. PubMed ID: 19845689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulindac sulfide-induced apoptosis in sinonasal cancer cells.
    Kim CH; Song KS; Kim KS; Kim JY; Lee BJ; Lee JG; Yoon JH
    Acta Otolaryngol; 2005 Feb; 125(2):201-6. PubMed ID: 15880954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.